Carter's CRI
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 2nd percentile, 5-year average 11.1x
#247 of 2972 stocks by PE (1 = cheapest)
Near the bottom of its 5-year range · 3rd percentile, 5-year average 2.7x
#1608 of 5311 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 6th percentile, 5-year average 0.7x
#773 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.13 | – | 2.66 | 3% (cheaper than usual) | #1608 of 5311 (1 = cheapest) |
| PE | 5.88 | 9.59 | 11.07 | 2% (cheaper than usual) | #247 of 2972 (1 = cheapest) |
| PS | 0.39 | 0.39 | 0.73 | 6% (cheaper than usual) | #773 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on CRI.